ANGIOTENSIN II RECEPTOR ANTAGONISTS AND TACROLIMUS
Candesartan and losartan do not affect the pharmacokinetics of tacrolimus. Concur- rent use with angiotensin II receptor antagonists may increase the risk of developing hyperkalaemia and/or nephrotoxicity in those taking tacrolimus.
Both renal function and potassium levels should be monitored if angiotensin II receptor antagonists are given with tacrolimus.
Both renal function and potassium levels should be monitored if angiotensin II receptor antagonists are given with tacrolimus.